NFKB1 and B-cell chronic lymphocytic leukemia: Other prominent signatures emerging from genes upregulated in the EMC cell lines compared to primary CLL tumors were “mTorc1 signaling” and “TNFα signaling via NFkB” (both with p = ∼10−5, FDR<0.05; Supplementary Figure 2C).